You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 7

April-1 2021 - 262 articles

Cover Story: Testicular germ cell tumors are the most common malignancy of young men, and the incidence is rising worldwide. These tumors are curable with conventional chemotherapy, although a significant number of patients are resistant and die of progressive disease. Epigenetics appears to play an especially important role in the pathogenesis and therapeutic responses of testicular germ cell tumors. Singh et al. review the current evidence that supports a central role for epigenetics in the etiology, progression, and treatment of this common form of testicular cancer. A working model is developed that postulates that epigenetic features that drive testicular cancer malignancy also enable these tumors to be cured at a high rate with chemotherapy. This model provides new insights related to testicular cancer chemoresistance and potential vulnerabilities to epigenetic-based therapies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (262)

  • Article
  • Open Access
8 Citations
3,747 Views
15 Pages

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A

  • Zoë S. Walters,
  • Ewa Aladowicz,
  • Barbara Villarejo-Balcells,
  • Gary Nugent,
  • Joanna L. Selfe,
  • Paul Eve,
  • Julian Blagg,
  • Olivia Rossanese and
  • Janet Shipley

6 April 2021

Histone demethylases are epigenetic modulators that play key roles in regulating gene expression related to many critical cellular functions and are emerging as promising therapeutic targets in a number of tumor types. We previously identified histon...

  • Article
  • Open Access
14 Citations
2,989 Views
16 Pages

Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total Laryngectomy

  • Patricia García-Cabo,
  • Fernando López,
  • Mario Sánchez-Canteli,
  • Laura Fernández-Vañes,
  • César Álvarez-Marcos,
  • José Luis Llorente,
  • Maria Ángeles de la Rúa,
  • Pilar Blay and
  • Juan P. Rodrigo

6 April 2021

Background: We performed a comparative analysis between an organ-preservation protocol and surgery followed by radiotherapy in patients with locally advanced squamous cell carcinoma of the larynx and hypopharynx; Methods: 60 previously untreated pati...

  • Article
  • Open Access
8 Citations
3,042 Views
14 Pages

Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?

  • Iuliu Sbiera,
  • Stefan Kircher,
  • Barbara Altieri,
  • Martin Fassnacht,
  • Matthias Kroiss and
  • Silviu Sbiera

6 April 2021

A clinically relevant proportion of adrenocortical carcinoma (ACC) cases shows a tendency to metastatic spread. The objective was to determine whether the epithelial to mesenchymal transition (EMT), a mechanism associated with metastasizing in severa...

  • Article
  • Open Access
10 Citations
3,829 Views
17 Pages

Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies

  • Marta Jaén,
  • Rubén A. Bartolomé,
  • Carmen Aizpurua,
  • Ángela Martin-Regalado,
  • J. Ignacio Imbaud and
  • J. Ignacio Casal

6 April 2021

Background: IL13Rα2 is reportedly a promising therapeutic target in different cancers. Still, no specific antagonists have reached the clinics yet. We investigated the use of a IL-13/IL13Rα2 binding motif, called D1, as a new target for the developme...

  • Review
  • Open Access
104 Citations
7,436 Views
19 Pages

Plasma-Treated Solutions (PTS) in Cancer Therapy

  • Hiromasa Tanaka,
  • Sander Bekeschus,
  • Dayun Yan,
  • Masaru Hori,
  • Michael Keidar and
  • Mounir Laroussi

6 April 2021

Cold physical plasma is a partially ionized gas generating various reactive oxygen and nitrogen species (ROS/RNS) simultaneously. ROS/RNS have therapeutic effects when applied to cells and tissues either directly from the plasma or via exposure to so...

  • Article
  • Open Access
11 Citations
4,315 Views
20 Pages

Effects of Epstein-Barr Virus Infection on the Risk and Prognosis of Primary Laryngeal Squamous Cell Carcinoma: A Hospital-Based Case-Control Study in Taiwan

  • Li-Ang Lee,
  • Tuan-Jen Fang,
  • Hsueh-Yu Li,
  • Hai-Hua Chuang,
  • Chung-Jan Kang,
  • Kai-Ping Chang,
  • Chun-Ta Liao,
  • Tse-Ching Chen,
  • Chung-Guei Huang and
  • Tzu-Chen Yen

6 April 2021

Mounting molecular evidence supports Epstein–Barr virus (EBV) involvement in the pathogenesis of laryngeal squamous cell carcinoma (LSCC); however, the epidemiological data are inconsistent. In this retrospective case-control study, we aimed to deter...

  • Review
  • Open Access
13 Citations
5,318 Views
23 Pages

Roles of microRNAs in Regulating Cancer Stemness in Head and Neck Cancers

  • Melysa Fitriana,
  • Wei-Lun Hwang,
  • Pak-Yue Chan,
  • Tai-Yuan Hsueh and
  • Tsai-Tsen Liao

6 April 2021

Head and neck squamous cell carcinomas (HNSCCs) are epithelial malignancies with 5-year overall survival rates of approximately 40–50%. Emerging evidence indicates that a small population of cells in HNSCC patients, named cancer stem cells (CSCs), pl...

  • Article
  • Open Access
35 Citations
6,629 Views
20 Pages

6 April 2021

Aspirin can prevent or inhibit inflammation-related cancers, such as colorectal cancer and hepatocellular carcinoma (HCC). However, the effectiveness of chemotherapy may be compromised by activating oncogenic pathways in cancer cells. Elucidation of...

  • Article
  • Open Access
23 Citations
3,560 Views
12 Pages

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity

  • Ashiq Legi,
  • Emma Rodriguez,
  • Thomas K. Eckols,
  • Cyrus Mistry and
  • Prema Robinson

6 April 2021

Background: Doxorubicin (DOX), used in chemotherapeutic regimens in many cancers, has been known to induce, cardiotoxicity and life-threatening heart failure or acute coronary syndromes in some patients. We determined the role of Substance P (SP), a...

  • Review
  • Open Access
20 Citations
4,948 Views
25 Pages

6 April 2021

Despite multimodal treatment, survival chances for high-risk neuroblastoma patients remain poor. Immunotherapeutic approaches focusing on the activation and/or modification of host immunity for eliminating tumor cells, such as chimeric antigen recept...

of 27

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694